{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T05:32:01Z","timestamp":1766467921021},"reference-count":51,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T00:00:00Z","timestamp":1714694400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.revmed.2024.05.002","type":"journal-article","created":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T11:31:53Z","timestamp":1716895913000},"page":"549-558","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Orientation diagnostique devant une anomalie du TP ou du TCA"],"prefix":"10.1016","volume":"45","author":[{"given":"S.","family":"Clauser","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Calmette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.revmed.2024.05.002_bib0260","first-page":"1","article-title":"Temps de Quick (taux de prothrombine), INR","volume":"12","author":"Jourdi","year":"2017","journal-title":"EMC\u00a0\u2013\u00a0Trait\u00e9 de M\u00e9decine AKOS"},{"issue":"0","key":"10.1016\/j.revmed.2024.05.002_bib0265","first-page":"1","article-title":"Allongement du temps de c\u00e9phaline avec activateur","volume":"0","author":"Calmette","year":"2017","journal-title":"EMC\u00a0\u2013\u00a0Trait\u00e9 de M\u00e9decine AKOS"},{"year":"2013","series-title":"D\u00e9crets, arr\u00eat\u00e9s, circulaires\u00a0: nomenclature sous chapitre 5-02-H\u00e9mostase et coagulation. D\u00e9cision du 11\u00a0f\u00e9vrier 2013\u00a0de l\u2019Union nationale des caisses d\u2019assurance maladie relative \u00e0 la liste des actes et prestations pris en charge par l\u2019assurance maladie","key":"10.1016\/j.revmed.2024.05.002_bib0270"},{"issue":"9","key":"10.1016\/j.revmed.2024.05.002_bib0275","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.annfar.2012.06.009","article-title":"Examens pr\u00e9-interventionnels syst\u00e9matiques","volume":"31","author":"Molliex","year":"2012","journal-title":"Ann Fr Anesth Reanim"},{"issue":"2","key":"10.1016\/j.revmed.2024.05.002_bib0280","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2753.2007.00875.x","article-title":"Prevalence and type of pre-analytical problems for inpatients samples in coagulation laboratory","volume":"14","author":"Salvagno","year":"2008","journal-title":"J Eval Clin Pract"},{"issue":"3","key":"10.1016\/j.revmed.2024.05.002_bib0285","first-page":"1","article-title":"H\u00e9parine, d\u00e9riv\u00e9s h\u00e9pariniques et antagonistes de la vitamine K, maniement, surveillance biologique, gestion des complications","volume":"8","author":"Gouin-Thibault","year":"2013","journal-title":"EMC\u00a0\u2013\u00a0Trait\u00e9 de M\u00e9decine AKOS"},{"year":"2013","series-title":"Dabigatran etexilate et examens de biologie m\u00e9dicale","author":"Siguret","key":"10.1016\/j.revmed.2024.05.002_bib0290"},{"year":"2012","series-title":"Rivaroxaban et tests de biologie m\u00e9dicale","author":"Gouin-Thibault","key":"10.1016\/j.revmed.2024.05.002_bib0295"},{"year":"2013","series-title":"Apixaban et examens de biologie m\u00e9dicale","author":"Gouin-Thibault","key":"10.1016\/j.revmed.2024.05.002_bib0300"},{"issue":"3","key":"10.1016\/j.revmed.2024.05.002_bib0305","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1365-2141.2011.08990.x","article-title":"False prolongation of the activated partial thromboplastin time (aPTT) in inflammatory patients: interference of C-reactive protein","volume":"157","author":"van Rossum","year":"2012","journal-title":"Br J Haematol"},{"issue":"9","key":"10.1016\/j.revmed.2024.05.002_bib0310","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.cgh.2013.02.026","article-title":"Coagulation in liver disease: a guide for the clinician","volume":"11","author":"Northup","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.revmed.2024.05.002_bib0315","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/00000658-199508000-00002","article-title":"Orthotopic liver transplantation in fulminant and subfulminant hepatitis. The Paul Brousse experience","volume":"222","author":"Bismuth","year":"1995","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.revmed.2024.05.002_bib0320","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/MOG.0000000000000635","article-title":"Coagulation testing and management in liver disease patients","volume":"36","author":"Stotts","year":"2020","journal-title":"Curr Opin Gastroenterol"},{"issue":"5","key":"10.1016\/j.revmed.2024.05.002_bib0325","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/bjh.17172","article-title":"Disseminated intravascular coagulation: epidemiology, biomarkers, and management","volume":"192","author":"Adelborg","year":"2021","journal-title":"Br J Haematol"},{"issue":"12","key":"10.1016\/j.revmed.2024.05.002_bib0330","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1097\/01.CCM.0000147769.07699.E3","article-title":"Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation","volume":"32","author":"Bakhtiari","year":"2004","journal-title":"Crit Care Med"},{"issue":"2","key":"10.1016\/j.revmed.2024.05.002_bib0335","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1136\/jclinpath-2019-205997","article-title":"Laboratory assessment of vitamin K status","volume":"73","author":"Card","year":"2020","journal-title":"J Clin Pathol"},{"issue":"4","key":"10.1016\/j.revmed.2024.05.002_bib0340","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1093\/nutrit\/nuab061","article-title":"Vitamin K\u00a0\u2013\u00a0sources, physiological role, kinetics, deficiency, detection, therapeutic use, and toxicity","volume":"80","author":"Mladenka","year":"2022","journal-title":"Nutr Rev"},{"issue":"5","key":"10.1016\/j.revmed.2024.05.002_bib0345","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/MD.0b013e31826b971f","article-title":"Lupus anticoagulant-hypoprothrombinemia syndrome: report of 8 cases and review of the literature","volume":"91","author":"Mazodier","year":"2012","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"10.1016\/j.revmed.2024.05.002_bib0350","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/ajh.20750","article-title":"Quinidine-induced lupus anticoagulant, hypoprothrombinemia, and antiprothrombin antibodies","volume":"82","author":"Clauser","year":"2007","journal-title":"Am J Hematol"},{"issue":"5","key":"10.1016\/j.revmed.2024.05.002_bib0355","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/bjh.17308","article-title":"Acquired factor V inhibitor: a nation-wide study of 38 patients","volume":"192","author":"Goulenok","year":"2021","journal-title":"Br J Haematol"},{"issue":"Suppl. 1","key":"10.1016\/j.revmed.2024.05.002_bib0360","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1046\/j.1365-2516.2001.00100.x","article-title":"Current therapy for rare factor deficiencies","volume":"7","author":"Di Paola","year":"2001","journal-title":"Haemophilia"},{"issue":"3","key":"10.1016\/j.revmed.2024.05.002_bib0365","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1046\/j.1365-2141.2002.03545.x","article-title":"Factor VII deficiency","volume":"118","author":"Perry","year":"2002","journal-title":"Br J Haematol"},{"issue":"9","key":"10.1016\/j.revmed.2024.05.002_bib0370","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1111\/j.1538-7836.2012.04844.x","article-title":"Classification of rare bleeding disorders (RBDs) based on the association between coagulant factor activity and clinical bleeding severity","volume":"10","author":"Peyvandi","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"2","key":"10.1016\/j.revmed.2024.05.002_bib0375","first-page":"63","article-title":"Isolated acquired factor VII deficiency: review of the literature","volume":"71","author":"Mulliez","year":"2016","journal-title":"Acta Clin Belg"},{"issue":"1","key":"10.1016\/j.revmed.2024.05.002_bib0380","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.hemonc.2018.05.002","article-title":"Acquired factor X deficiency in light-chain (AL) amyloidosis is rare and associated with advanced disease","volume":"12","author":"Patel","year":"2019","journal-title":"Hematol Oncol Stem Cell Ther"},{"issue":"1","key":"10.1016\/j.revmed.2024.05.002_bib0385","first-page":"52","article-title":"Paraneoplastic bleeding disorder due to isolated hypofibrinogenemia: a case report","volume":"13","author":"Cvetkovic","year":"2009","journal-title":"Hippokratia"},{"issue":"2","key":"10.1016\/j.revmed.2024.05.002_bib0390","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1046\/j.1365-2141.2001.02892.x","article-title":"The dysfibrinogenaemias","volume":"114","author":"Roberts","year":"2001","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.revmed.2024.05.002_bib0395","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1365-2516.2004.00944.x","article-title":"The rare coagulation disorders\u00a0\u2013\u00a0review with guidelines for management from the United Kingdom Haemophilia Centre Doctors\u2019 Organisation","volume":"10","author":"Bolton-Maggs","year":"2004","journal-title":"Haemophilia"},{"issue":"2","key":"10.1016\/j.revmed.2024.05.002_bib0400","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1538-7836.2003.t01-1-00553.x","article-title":"Rare Bleeding Disorder Registry: deficiencies of factors II, V, VII, X, XIII, fibrinogen and dysfibrinogenemias","volume":"2","author":"Acharya","year":"2004","journal-title":"J Thromb Haemost"},{"year":"2021","series-title":"Protocole National de Diagnostic et de Soins (PNDS)\u00a0: d\u00e9ficits rares en prot\u00e9ines de la coagulation","key":"10.1016\/j.revmed.2024.05.002_bib0405"},{"issue":"4","key":"10.1016\/j.revmed.2024.05.002_bib0410","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1160\/TH16-02-0082","article-title":"Thromboembolism in patients with congenital afibrinogenaemia. Long-term observational data and systematic review","volume":"116","author":"Nagler","year":"2016","journal-title":"Thromb Haemost"},{"issue":"3","key":"10.1016\/j.revmed.2024.05.002_bib0415","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/bjh.13058","article-title":"Guideline for the diagnosis and management of the rare coagulation disorders: a United Kingdom Haemophilia Centre Doctors\u2019 Organization guideline on behalf of the British Committee for Standards in Haematology","volume":"167","author":"Mumford","year":"2014","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.revmed.2024.05.002_bib0420","first-page":"566","article-title":"Association of congenital deficiency of multiple vitamin K-dependent coagulation factors and the phenotype of the warfarin embryopathy: clues to the mechanism of teratogenicity of coumarin derivatives","volume":"41","author":"Pauli","year":"1987","journal-title":"Am J Hum Genet"},{"issue":"3","key":"10.1016\/j.revmed.2024.05.002_bib0425","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/sj.jid.5700610","article-title":"Pseudoxanthoma elasticum-like phenotype with cutis laxa and multiple coagulation factor deficiency represents a separate genetic entity","volume":"127","author":"Vanakker","year":"2007","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1016\/j.revmed.2024.05.002_bib0430","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.revmed.2017.02.006","article-title":"Diagnostic biologique du syndrome des antiphospholipides\u00a0: des crit\u00e8res \u00e0 la pratique","volume":"39","author":"Joste","year":"2018","journal-title":"Rev Med Interne"},{"issue":"10","key":"10.1016\/j.revmed.2024.05.002_bib0435","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1002\/art.42624","article-title":"The 2023 ACR\/EULAR Antiphospholipid Syndrome Classification Criteria","volume":"75","author":"Barbhaiya","year":"2023","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"10.1016\/j.revmed.2024.05.002_bib0440","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"9","key":"10.1016\/j.revmed.2024.05.002_bib0445","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.revmed.2023.08.004","article-title":"French National Diagnostic and Care Protocol for antiphospholipid syndrome in adults and children","volume":"44","author":"Amoura","year":"2023","journal-title":"Rev Med Interne"},{"issue":"12","key":"10.1016\/j.revmed.2024.05.002_bib0450","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.revmed.2018.08.005","article-title":"La maladie de Willebrand","volume":"39","author":"Calmette","year":"2018","journal-title":"Rev Med Interne"},{"issue":"2","key":"10.1016\/j.revmed.2024.05.002_bib0455","doi-asserted-by":"crossref","first-page":"646","DOI":"10.3390\/ijerph19020646","article-title":"Haemophilia in France: modelisation of the clinical pathway for patients","volume":"19","author":"Beny","year":"2022","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"10.1016\/j.revmed.2024.05.002_bib0460","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41572-021-00278-x","article-title":"Haemophilia","volume":"7","author":"Berntorp","year":"2021","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"10.1016\/j.revmed.2024.05.002_bib0465","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3324\/haematol.2019.232132","article-title":"Hemophilia therapy: the future has begun","volume":"105","author":"Mannucci","year":"2020","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.revmed.2024.05.002_bib0470","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.hoc.2021.07.012","article-title":"Factor XI deficiency","volume":"35","author":"Lewandowska","year":"2021","journal-title":"Hematol Oncol Clin North Am"},{"issue":"4","key":"10.1016\/j.revmed.2024.05.002_bib0475","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1177\/107602960401000407","article-title":"Thrombosis-free surgical procedures in severe (Homozygote) factor XII deficiency: report of four additional cases and literature review","volume":"10","author":"Girolami","year":"2004","journal-title":"Clin Appl Thromb Hemost"},{"issue":"7","key":"10.1016\/j.revmed.2024.05.002_bib0480","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/ajh.24777","article-title":"Acquired hemophilia A: updated review of evidence and treatment guidance","volume":"92","author":"Kruse-Jarres","year":"2017","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.revmed.2024.05.002_bib0485","first-page":"179","article-title":"[Acquired hemophilia A associated with bullous pemphigoid and multiple myeloma: a case report]","volume":"77","author":"Sourdeau","year":"2019","journal-title":"Ann Biol Clin (Paris)"},{"issue":"1","key":"10.1016\/j.revmed.2024.05.002_bib0490","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/hae.14692","article-title":"Drug-associated acquired hemophilia A: an analysis based on 185 cases from the WHO pharmacovigilance database","volume":"29","author":"Konstantinov","year":"2023","journal-title":"Haemophilia"},{"issue":"7","key":"10.1016\/j.revmed.2024.05.002_bib0495","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.3324\/haematol.2019.230771","article-title":"International recommendations on the diagnosis and treatment of acquired hemophilia A","volume":"105","author":"Tiede","year":"2020","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.revmed.2024.05.002_bib0500","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.revmed.2013.02.039","article-title":"Syndrome de Willebrand acquis\u00a0: \u00e9tude d\u2019une s\u00e9rie de neuf patients et revue de la litt\u00e9rature","volume":"35","author":"Boissier","year":"2014","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2024.05.002_bib0505","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.thromres.2021.11.014","article-title":"A new case of acquired haemophilia B in the context of liver autoimmune disease","volume":"209","author":"Alonso Escobar","year":"2022","journal-title":"Thromb Res"},{"issue":"3","key":"10.1016\/j.revmed.2024.05.002_bib0255","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1007\/s11239-019-01879-w","article-title":"Influence of factor XII deficiency on activated partial thromboplastin time (aPTT) in critically ill patients","volume":"48","author":"Bachler","year":"2019","journal-title":"J Thromb Thrombolysis"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866324005642?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866324005642?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T10:16:40Z","timestamp":1728555400000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866324005642"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":51,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S0248866324005642"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2024.05.002","relation":{},"ISSN":["0248-8663"],"issn-type":[{"type":"print","value":"0248-8663"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Orientation diagnostique devant une anomalie du TP ou du TCA","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2024.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI).","name":"copyright","label":"Copyright"}]}}